dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2013-09-30T18:28:33Z
dc.date.accessioned2014-05-20T13:42:01Z
dc.date.accessioned2022-10-05T14:01:51Z
dc.date.available2013-09-30T18:28:33Z
dc.date.available2014-05-20T13:42:01Z
dc.date.available2022-10-05T14:01:51Z
dc.date.created2013-09-30T18:28:33Z
dc.date.created2014-05-20T13:42:01Z
dc.date.issued2010-09-01
dc.identifierTheriogenology. New York: Elsevier B.V., v. 74, n. 4, p. 596-601, 2010.
dc.identifier0093-691X
dc.identifierhttp://hdl.handle.net/11449/14590
dc.identifier10.1016/j.theriogenology.2010.03.010
dc.identifierWOS:000281261600014
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3889929
dc.description.abstractThe objective was to evaluate the parthenogenetic activation of domestic cat oocytes. Cumulus-oocyte complexes matured for 36 h were subjected to three protocols of parthenogenetic activation: Group 1 - ionomycin + cycloheximide; Group 2 - ionomycin + roscovitine; and Group 3 - ionomycin + strontium. As a control, a fourth group of oocytes were cultured in the absence of any activation agent. In all groups, embryos were cultured in SOFaa for 72 h after activation and evaluated for activation rate, cleavage, and embryonic development using Hoechst 33342. There were no significant differences among the three treated groups for rates of activated oocytes (70.1 +/- 4.3, 75.5 +/- 4.7, and 61.9 +/- 7.2%, for Treatments 1, 2, and 3 respectively; mean +/- SEM), or cleavage (48.1 +/- 5.9, 47.4 +/- 3.8, and 33.3 +/- 6.8%). However, activation and cleavage rates were higher (P < 0.05) than those in the control group (35.5 +/- 6.4 and 11.8 +/- 4.0%). There were no significant differences among treatment groups for proportion of embryos with 2-10 cells, 10-16 cells, and morulas. In the Control group, the embryo production rate was lower (P < 0.05), although the activation rate was high. The authors concluded that all three treatments effectively induced parthenogenetic activation of domestic cat oocytes. However, to optimize the use of strontium and roscovitine, a dose response and the effect of the presence of Ca(++) in the medium requires further study. (C) 2010 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationTheriogenology
dc.relation2.136
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectStrontium
dc.subjectRoscovitine
dc.subjectCycloheximide
dc.subjectArtificial activation
dc.subjectFeline oocytes
dc.titleParthenogenetic development of domestic cat oocytes treated with ionomycin, cycloheximide, roscovitine and strontium
dc.typeArtigo


Este ítem pertenece a la siguiente institución